✦ LIBER ✦

Counterpoint from the trenches: A pragmatic approach to therapeutic trials in rheumatoid arthritis

✍ Scribed by Vibeke Strand

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 118 KB
Volume: 50
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.20153

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apoptosis of rheumatoid synovial cells b

Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: A potential therapeutic approach to rheumatoid arthritis

✍ Takao Nagashima; Hitoaki Okazaki; Kazuo Yudoh; Hiroaki Matsuno; Seiji Minota 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

The effect of therapeutic glucocorticoid

The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis

✍ John R. Kirwan; Sarah H. Hickey; Roger Hällgren; Herman Mielants; Ewa Björck; To 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

How to report radiographic data in rando

How to report radiographic data in randomized clinical trials in rheumatoid arthritis: Guidelines from a roundtable discussion

✍ Van der heijde, D�sir�e ;Simon, Lee ;Smolen, Josef ;Strand, Vibeke ;Sharp, John 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

A cautionary approach to clinical guidel

A cautionary approach to clinical guidelines: Comment on the guidelines for monitoring drug therapy in rheumatoid arthritis

✍ A. S. Russell; W. P. Maksymowych 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

The relationship of serum infliximab con

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

✍ E. William St.Clair; Carrie L. Wagner; Adedigbo A. Fasanmade; Benjamin Wang; Tho 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract ## Objective To investigate the relationship between serum concentrations of infliximab, a monoclonal anti–tumor necrosis factor α antibody, and clinical improvement from infliximab therapy for rheumatoid arthritis (RA). ## Methods Multiple blood samples were obtained from each of 42

Evaluation of the safety of rituximab in

Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

✍ Maria W. Greenwald; William J. Shergy; Jeffrey L. Kaine; Marianne T. Sweetser; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views